Biohaven Therapeutics Ltd., a subsidiary of Biohaven Pharmaceutical Holding Company Ltd., along with CD3 and LICR at KU Leuven, announced that they have entered...
Changing business priorities in the face of the COVID-19 pandemic have significantly increased demand among U.S. enterprises for digital transformation services, according to a...
ABCT, the Accelerator for Biosciences in Connecticut, announced the second cohort of emerging biosciences ventures invited to participate in the annual program. Nine ventures...
